Literature DB >> 27739364

miRNA 21: Diagnostic Prognostic and Therapeutic Marker for Oral Cancer.

Shreyas Shah, Kiran Jadhav1, Vandana Shah, Nidhi Gupta, Kapil Dagrus.   

Abstract

The vast majority of cancer epigenetic research is now focused on micro RNA (miRNA). Though thousands of miRNA have been identified, the validation of their role is a continuous process. AIM: the aim of this paper is to comprehensively review the role of miRNA 21 in Oral cancer as a marker for diagnosis, prognosis and therapeutic target.
METHOD: The data was collected from major search engines like PubMed, Science Direct, Cochrane library and Google Patents with the key words miRNA 21, miRNA and Oral Cancer, miRNA 21 prognostic role, miRNA therapeutic target etc. The articles published in the period of 2001 to 2016 in English language only were considered for this review. Articles in other language and focusing cancer other than oral cancer were beyond the scope of review and were excluded. Articles pertaining to Oral squamous cell carcinoma only were included in this review. The data synthesized was comprehensively categorized in to diagnostic, prognostic and therapeutic role along with targets of miRNA 21.
CONCLUSION: miRNA 21 mainly targets the tumour suppressor genes and thus affects the process of carcinogenesis. The identification of expression of various markers associated with carcinogenesis will help in diagnosis of lesion. miRNA 21 expression is negatively correlated with prognosis of Oral cancer. The addition of nucleic acid constructer along with vector carrying anticancer agents in the promoter sequence of miRNA 21 has lot of therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27739364     DOI: 10.2174/2211536605666160919115323

Source DB:  PubMed          Journal:  Microrna


  6 in total

1.  Expression of Salivary miRNA 21 in Oral Submucous Fibrosis (OSMF): An Observational Study.

Authors:  Shesha R Prasad; Anuradha Pai; K Shyamala; Anisha Yaji
Journal:  Microrna       Date:  2020

2.  A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma.

Authors:  Davide B Gissi; Luca Morandi; Andrea Gabusi; Achille Tarsitano; Claudio Marchetti; Francesca Cura; Annalisa Palmieri; Lucio Montebugnoli; Sofia Asioli; Maria P Foschini; Luca Scapoli
Journal:  Int J Mol Sci       Date:  2018-06-16       Impact factor: 5.923

3.  Circulating miR-21 as a prognostic and predictive biomarker in oral squamous cell carcinoma.

Authors:  Nosheen Mahmood; Muhammad Hanif; Akhtar Ahmed; Qamar Jamal; Shamim Mushtaq; Adnan Khan; Muhammad Saqib
Journal:  Pak J Med Sci       Date:  2019 Sep-Oct       Impact factor: 1.088

Review 4.  Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics.

Authors:  Ana Capote-Moreno; Eva Ramos; Javier Egea; Francisco López-Muñoz; Emilio Gil-Martín; Alejandro Romero
Journal:  Cancers (Basel)       Date:  2019-11-02       Impact factor: 6.639

5.  miRNA-21 plays an important role in necrotizing enterocolitis.

Authors:  Wen Li; Xiaoyang Huang; Dan Bi
Journal:  Arch Med Sci       Date:  2019-09-17       Impact factor: 3.318

Review 6.  The Connection between MicroRNAs and Oral Cancer Pathogenesis: Emerging Biomarkers in Oral Cancer Management.

Authors:  Ciprian Osan; Sergiu Chira; Andreea Mihaela Nutu; Cornelia Braicu; Mihaela Baciut; Schuyler S Korban; Ioana Berindan-Neagoe
Journal:  Genes (Basel)       Date:  2021-12-15       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.